Treatment of urinary tract infection with pivampicillin. A new ampicillin derivative.
D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use* / Q000652:urine; D001219:Aspartate Aminotransferases / Q000097:blood; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006207:Half-Life; D006801:Humans; D007408:Intestinal Absorption; D008111:Liver Function Tests; D008297:Male; D011512:Proteus Infections / Q000188:drug therapy; D011513:Proteus mirabilis; D013997:Time Factors; D014552:Urinary Tract Infections / Q000188:drug therapy*; D014631:Valerates / Q000627:therapeutic use
D014631:Valerates; D000667:Ampicillin; D001219:Aspartate Aminotransferases